Day 3 and last day of ICGBS 2021!

23 July, 2021

Today’s the last day of our online International Conference on Group B Strep (ICGBS) 2021! We hope you will join this collaboration of over 440 registrants representing 42 countries for today’s presentations and also to view any presentations you missed from Day 1 and Day 2 which can all be found in our Presentation Gallery. Registration is free, quick and easy at gbsi.me/ICGBS2021

Today’s presentations (uploaded for ease of viewing from any time zone):

July 22 – Novel Approaches and Research

Characterization of a novel GBS colonization factor – Laura C. Cook, PhD

Investigating mechanisms of persistent Group B Streptococcus colonization after intrapartum antibiotic prophylaxis treatment – Macy E. Pell, BS, PhD candidate

Antibiotic adjuvants: rejuvenating our current arsenal of antimicrobials against Group B Streptococcus – Sabrina K. Spicer, BS, current PhD student

Molecular characterization of invasive Group B streptococcus in South Africa, 2019-2020 – Buhle Ntozini, BMedSci (Hons)

A mouse model reproducing the pathophysiology of neonatal group B streptococcal disease – Elva Bonifácio Andrade, PhD

Commensal Streptococcus salivarius overcomes suppression of growth by pathogenic Group B Streptococcus – Rebecca E. Moore, BS, MS

A type VII secretion system in Group B Streptococcus mediates cytotoxicity and virulence – Brady Spencer, PhD

Please be sure to check out our virtual Research Wall to learn of GBS research efforts worldwide!

Best!

Marti

(Ms.) Marti Perhach

CEO/Cofounder

Group B Strep International

+1 909 620-7214

marti.perhach@gbs-intl.org

groupbstrepinternational@gmail.com

www.groupbstrepinternational.org

Promoting awareness and prevention of group B strep disease in babies before birth through early infancy

CHIFA profile: Marti Perhach is the CEO and Founder of Group B Strep International (GBSI) in the USA. marti.perhach AT gbs-intl.org